Clinical Trial News and Research

RSS

New cancer center at NewYork-Presbyterian/Weill Cornell

NewYork-Presbyterian Hospital/Weill Cornell Medical Center has created an expanded cancer program dedicated to advancing research, prevention and treatment of the disease. The new Cancer Center is led by renowned cancer physician-scientist Dr. Andrew Dannenberg.

5 Feb 2008

Resisting lung cancer recurrence - Vaccine booster gives persistent immune response

What if we could prevent cancer recurrence for years after surgery by giving simple recall injections every two or three years? This concept may no longer be a fantasy.

4 Feb 2008

Anemia treatment may be a double-edged sword

Erythropoietin has so far been known to doctors as a hormone that boosts red-blood-cell production.

4 Feb 2008

A possible H5N1 vaccine

A vaccine against the most common and deadliest strain of avian flu, H5N1, has been engineered and tested by researchers at the University of Pittsburgh's Center for Vaccine Research and Novavax Inc.

4 Feb 2008

Novel wound-healing peptide gel

First-String Research, Inc. (FSR), a spin-off biotechnology company from the Medical University of South Carolina (MUSC), has begun the human clinical trial process for its unique, wound-healing peptide gel.

4 Feb 2008

Researchers seek trial participants for experimental HIV vaccine called PENNVAX-B

University of Pennsylvania School of Medicine researchers are recruiting healthy, HIV-negative adults to participate in a phase I clinical trial of an experimental HIV vaccine called PENNVAX-B, a DNA-based vaccine which is made using synthetic DNA-based HIV genes.

4 Feb 2008

Study confirms safety of BrachySil for treatment of inoperable pancreatic cancer

The results of a Phase IIa clinical trial of BrachySil for the treatment of advanced, inoperable pancreatic cancer were presented at American Society of Clinical Oncolgy-GI (ASCO-GI) this weekend in a poster presented by Dr. Paul Ross, Chief Investigator in the study and Consultant Medical Oncologist at Guy's and St. Thomas' NHS Foundation Trust.

30 Jan 2008

MUSC spin-off to test wound-healing peptide gel

30 Jan 2008

Kidney cancer drug attacks a major type of acute myeloid leukemia

A drug used to treat kidney cancer also targets a genetic mutation active in about one third of patients with acute myeloid leukemia (AML), the most common and lethal form of adult leukemia, researchers at The University of Texas M. D. Anderson Cancer Center report in the Jan. 29 edition of the Journal of the National Cancer Institute.

30 Jan 2008

New nanomedicine research for prostate cancer

The Prostate Cancer Foundation, largely through the generosity of David H. Koch, has given $5 million to four institutions, including Weill Cornell Medical College, to support novel research in prostate cancer. The gift is one of the largest-ever individual donations for prostate cancer research.

29 Jan 2008

New target found for asthma

An enzyme released by mast cells in the lungs appears to play a key role in the tightening of airways that is a hallmark of asthma -- pointing to a potential new target for treatment against the illness.

29 Jan 2008

Candidate malaria vaccine shows promise

A small clinical trial conducted by an international team of researchers in Mali has found that a candidate malaria vaccine was safe and elicited strong immune responses in the 40 Malian adults who received it.

24 Jan 2008

Computer-based tool aids research, helps thwart questionable publication practices

A new computer-based text-searching tool developed by UT Southwestern Medical Center researchers automatically and quickly compares multiple documents in a database for similarities, providing a more efficient method to carry out literature searches, as well as offering scientific journal editors a new tool to thwart questionable publication practices.

24 Jan 2008

Gene variations associated with effectiveness of blood pressure medications

Patients with hypertension and certain gene variations experienced varying results with some blood pressure medications, suggesting matching a patient's genotype with certain hypertension medications could result in more favorable outcomes, according to a study in the January 23 issue of JAMA: The Journal of the American Medical Association.

23 Jan 2008

Treatment with hormone suppression therapy and radiation improves survival for certain prostate cancer patients

Men with localized prostate cancer who were treated with male hormone suppression therapy and radiation treatment had longer survival, but those with moderate to high levels of other illnesses did not experience this effect, according to a study in the January 23 issue of JAMA: The Journal of the American Medical Association.

23 Jan 2008

Duloxetine does not relieve painful physical symptoms in depression

An analysis of the data which are available, published in the European Journal Psychotherapy and Psychosomatics, discloses that the maker's claims are not warranted.

22 Jan 2008

Stem cell research aims to tackle Parkinson's disease

Scientists in Sweden are developing new ways to grow brain cells in the laboratory that could one day be used to treat patients with Parkinson's disease, an international conference of biologists organised by the European Science Foundation (ESF) was told last week.

21 Jan 2008

National study will look at German-made heart pump for children needing heart transplants

Texas Children's Hospital has been named the national lead center for a 12-hospital, 36-month clinical trial of the German-manufactured pediatric heart pump called Berlin Heart EXCOR® Pediatric Ventricular Assist Device (VAD).

21 Jan 2008

Selective publication means unfavorable drug studies rarely get published

A new report claims that almost a third of the research done on antidepressant drugs is never published in medical literature and most of those unpublished reports are unfavorable.

20 Jan 2008

Cancer study finds adolescents don't get same access to latest treatments as younger patients

The overall survival rate from cancer now is lower in older adolescents and young adults with cancer than in younger children, in part because of a lack of access to clinical trials nationally for the older age group, according to a study by pediatric oncologists at Children's Hospital of Pittsburgh of UPMC.

16 Jan 2008

Clinical Trial News and Research

New cancer center at NewYork-Presbyterian/Weill Cornell

Resisting lung cancer recurrence - Vaccine booster gives persistent immune response

Anemia treatment may be a double-edged sword

A possible H5N1 vaccine

Novel wound-healing peptide gel

Researchers seek trial participants for experimental HIV vaccine called PENNVAX-B

Study confirms safety of BrachySil for treatment of inoperable pancreatic cancer

MUSC spin-off to test wound-healing peptide gel

Kidney cancer drug attacks a major type of acute myeloid leukemia

New nanomedicine research for prostate cancer

New target found for asthma

Candidate malaria vaccine shows promise

Computer-based tool aids research, helps thwart questionable publication practices

Gene variations associated with effectiveness of blood pressure medications

Treatment with hormone suppression therapy and radiation improves survival for certain prostate cancer patients

Duloxetine does not relieve painful physical symptoms in depression

Stem cell research aims to tackle Parkinson's disease

National study will look at German-made heart pump for children needing heart transplants

Selective publication means unfavorable drug studies rarely get published

Cancer study finds adolescents don't get same access to latest treatments as younger patients

Event guide: 15th World Clinical Biomarkers & CDx Europe eBook

Latest eBooks

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Driving innovation in Korean drug development

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer